1. Penela D, Van Huls Van Taxis C, Aquinaga L, Fernández-Armenta J, Mont L, Castel MA, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol 2013;62:1195–1202.
2. Baser K, Bas HD, Yokokawa M, Latchamsetty R, Morady F, Bogun F. Infrequent intraprocedural premature ventricular complexes: Implications for ablation outcome. J Cardiovasc Electrophysiol 2014;25:1088–92.
3. Hamon D, Abehsira G, Gu K, Liu A, Blaye-Felice Sadron M, Billet S, et al. Circadian variability patterns predict and guide premature ventricular contraction ablation procedural inducibility and outcomes. Heart Rhythm 2018;15:99–106.
4. Kinugawa T, Kurita T, Nohara R, Smith ML. A case of atrial tachycardia sensitive to increased caffeine intake. Int Heart J 2011;52:398–400.
5. Dixit S, Stein PK, Dewland TA, Dukes JW, Vittinghoff E, Heckbert SR, et al. Consumption of caffeinated products and cardiac ectopy. J Am Heart Assoc. 2016;5:e002503.
6. Voskoboinik A, Kalman JM, Kistler PM. Caffeine and arrhythmias: Time to grind the data. JACC Clin Electrophysiol 2018;4:425–32.
7. O’Neill SC, Eisner DA. A mechanism for the effects of caffeine on Ca2+ release during diastole and systole in isolated rat ventricular myocytes. J Physiol 1990;430:519–36.
8. Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, Shand DG. Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 1978:298:181–6.
9. Lemery R, Pecarskie A, Bernick J, Williams K, Wells GA. A prospective placebo controlled randomized study of caffeine in patients with supraventricular tachycardia undergoing electrophysiologic testing. J Cardiovasc Electrophysiol 2015;26:1–6.
10. Lin CI, Vassalle M. Role of calcium in the inotropic effects of caffeine in cardiac Purkinje fibers. Int J Cardiol 1983;3:421–34.
11. Zuchinali P, Ribeiro PA, Pemental M, da Rosa PR, Zimerman LI, Rohde LE. Effect of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies. Europace 2016;18:257–66.
12. Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF. The arrhythmogenic effects of caffeine in human beings. N Engl J Med 1983;308:814–6.
13. Strubelt O, Diederich KW. Experimental treatment of the acute cardiovascular toxicity of caffeine. J Toxicol Clin Toxicol 1993;37:29–33.
14. Goldberger JJ, Le FK, Lahiri M, Kannankeril PJ, Ng J, Kadish AH. Assessment of parasympathetic reactivation after exercise. Am J Physiol Heart Circ Physiol 2006;290:H2446–52.
15. Flueck JL, Schaufelberger F, Lienert M, Schäfer Olstad D, Wilhelm M, Perret C. Acute effects of caffeine on heart rate variability, blood pressure and tidal volume in paraplegic and tetraplegic compared to able-bodied individuals: A randomized, blinded trial. PLoS One 2016;11:e0165034.
16. Sondermeijer HP, van Marle AG, Kamen P, Krum H. Acute effects of caffeine on heart rate variability. Am J Cardiology 2002;90:906–7.
17. da Silva Rolim P, da Costa Matos RA, Von Koenig Soares EMK, Molina GE, da Cruz CJG. Caffeine increases parasympathetic reactivation without altering resting and exercise cardiac parasympathetic modulation: A balanced placebo design. Eur J Sport Sci 2019;19:490–8.
18. Ishida S, Ito M, Takahashi N, Fujino T, Akimitsu T, Saikawa T. Caffeine induces ventricular tachyarrhythmias possibly due to triggered activity in rabbits in vivo. Jpn Circ J 1996;60:157–65.
19. Chelsky LB, Cutler JE, Griffith K, Kron J, McClelland JH, McAnulty JH. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA 1990;264:2236–40.
20. Zuchinali P, Souza GC, Pimentel M, Chemello D, Zimerman A, Giaretta V, et al. Short-term effects of high-dose caffeine on cardiac arrhythmias in patients with heart failure: a randomized clinical trial. JAMA Intern Med 2016;176:1752–9.